Keeping Clean Where it Counts
The push for prophylaxis and treatment of SARS-CoV-2 oropharyngeal infection starts in the nose and mouth. A randomized trial by Choudhury et al. from Bangladesh has been overlooked by US public agencies but not the early treatment organizations around the world. In this prospective randomized controlled trial, n=606 high-risk subjects with incipient COVID-19 were randomized to 1% povidone-iodine (betadine) solution as a rinse was used for a target of every 4 hours versus lukewarm water for four weeks.
Join us for the next COVID Q & A with Dr. Peter McCullough, on Sept 29, Wednesday, at 6 PM ET, and an encore at 10 PM ET on America Out Loud Talk Radio. Listen on iHeart Radio, our world-class media player, or our free apps on Apple, Android, or Alexa.
5 comments